Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590–3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer

References

• Bertucci F, Ng CKY, Patsouris A, et al. Genomic characterization of metastatic breast cancers. Nature. 2019;569(7757):560–564.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Nagini S. Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med Chem. 2017;17(2):152–163.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641.
   PubMed Web of Science ®Google Scholar
• Zhao W, Lin X, Han H, et al. Long noncoding RNA H19 contributes to the proliferation and autophagy of glioma cells through mTOR/ULK1 pathway. Neuroreport. 2021;32(5):352–358.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhou K, Zhang X, et al. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells. Oncol Rep. 2021;45(4):1–13.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou P, Li P, et al. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1. Bioengineered. 2020;11(1):536–546.
   PubMed Web of Science ®Google Scholar
• Li Y, Ma HY, Hu XW, et al. LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway. Cancer Cell Int. 2020;20(1):200.
   PubMed Web of Science ®Google Scholar
• Yan L, Yang S, Yue C-X, et al. Long noncoding RNA H19 acts as a miR −340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Environ Toxicol. 2020;35(9):1015–1028.
   PubMed Web of Science ®Google Scholar
• Xiong H, Shen J, Chen Z, et al. H19/let‑7/Lin28 ceRNA network mediates autophagy inhibiting epithelial‑mesenchymal transition in breast cancer. Int J Oncol. 2020;56(3):794–806.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang X, Zheng Y, et al. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer. Aging (Albany NY). 2021;13(1):1153–1175.
   PubMedGoogle Scholar
• Wang S, Lan F, Xia Y. lncRA ANCR inhibits non-small cell lung cancer cell migration and invasion by inactivating TGF-β pathway. Med Sci Monit. 2018;24:6002–6009.
   PubMed Web of Science ®Google Scholar
• Qin S, Ning M, Liu Q, et al. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis. Bioengineered. 2021;12(1):5125–5137.
   PubMed Web of Science ®Google Scholar
• Hu X, Li Y, Kong D, et al. Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer. J Cell Physiol. 2019;234(7):10800–10808.
   PubMed Web of Science ®Google Scholar
• Liang Y, Chen X, Wu Y, et al. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ. 2018;25(11):1980–1995.
   PubMed Web of Science ®Google Scholar
• Zhao W, Chen T, Zhao Y. Upregulated lncRNA CASC9 contributes to progression of non-small cell lung cancer through inhibition of miR-335-3p and activation S100A14 Expression. Onco Targets Ther. 2020;569:6027–6036.
   Google Scholar
• Jiang B, Li Y, Qu X, et al. Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2. Int J Mol Med. 2018;42(5):2801–2810.
   PubMed Web of Science ®Google Scholar
• Liu H-Z, Shan T-D, Han Y, et al. Silencing long non-coding RNA CASC9 inhibits colorectal cancer cell proliferation by acting as a competing endogenous RNA of miR-576-5p to regulate AKT3. Cell Death Discov. 2020;6(1):115.
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu S, Tang L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021;12(1):162–171.
   PubMed Web of Science ®Google Scholar
• Li X, Chen B, Chi D, et al. lncRNA CASC9 regulates cell migration and invasion in hemangioma endothelial cells by targeting miR-125a-3p/Nrg1. Onco Targets Ther. 2019;12:423–432.
   PubMed Web of Science ®Google Scholar
• Shao G, Wang M, Fan X, et al. lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster. Int J Oncol. 2019;54(5):1665–1675.
   PubMed Web of Science ®Google Scholar
• Yan M, Ye L, Feng X, et al. MicroRNA-590-3p inhibits invasion and metastasis in triple-negative breast cancer by targeting Slug. Am J Cancer Res. 2020;10(3):965–974.
   PubMed Web of Science ®Google Scholar
• Abdolvahabi Z, Nourbakhsh M, Hosseinkhani S, et al. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53. J Cell Biochem. 2019;120(6):9356–9368.
   PubMed Web of Science ®Google Scholar
• Wang WT, Qi Q, Zhao P, et al. miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9. Biomed Pharmacother. 2018;107:1763–1769.
   PubMed Web of Science ®Google Scholar
• Gao J, Yu SR, Yuan Y, et al. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway. J Cell Physiol. 2019;234(2):1827–1841.
   PubMed Web of Science ®Google Scholar
• Guan H, Liu J, Lv P, et al. MicroRNA‑590 inhibits migration, invasion and epithelial‑to‑mesenchymal transition of esophageal squamous cell carcinoma by targeting low‑density lipoprotein receptor‑related protein 6. Oncol Rep. 2020;44(4):1385–1392.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chang J, Jiang W, et al. Long non-coding RNA CASC9/microRNA-590-3p axis participates in lutein-mediated suppression of breast cancer cell proliferation. Oncol Lett. 2021;22(1):544.
   PubMed Web of Science ®Google Scholar
• Yang C, Xu W, Gong J, et al. Six1 overexpression promotes glucose metabolism and invasion through regulation of GLUT3, MMP2 and snail in thyroid cancer cells. Onco Targets Ther. 2020;13:4855–4863.
   PubMed Web of Science ®Google Scholar
• Kong D, Li A, Liu Y, et al. SIX1 activates STAT3 signaling to promote the proliferation of thyroid carcinoma via EYA1. Front Oncol. 2019;9:1450.
   PubMed Web of Science ®Google Scholar
• Tang D, Zhao L, Peng C, et al. CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p. J Cell Biochem. 2019;120(9):16128–16142.
   PubMed Web of Science ®Google Scholar
• Smith AL, Iwanaga R, Drasin DJ, et al. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene. 2012;31(50):5162–5171.
   PubMed Web of Science ®Google Scholar
• Micalizzi DS, Wang CA, Farabaugh SM, et al. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Res. 2010;70(24):10371–10380.
   PubMed Web of Science ®Google Scholar
• Wan J, Yang J, Qiao C, et al. MicroRNA-362 inhibits cell proliferation and invasion by directly targeting SIX1 in colorectal cancer. Yonsei Med J. 2019;60(5):414–422.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhou X, Chen Y, et al. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Neoplasma. 2020;67(1):147–157.
   PubMed Web of Science ®Google Scholar
• Lv DQ, Li HY, Wu XM, et al. MiR-188 inhibits proliferation and promotes apoptosis of lung adenocarcinoma cells by targeting SIX1 to negatively regulate ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24(2):721–727.
   PubMed Web of Science ®Google Scholar
• Yang ZC, Yi MJ, Shan YC, et al. Targeted inhibition of Six1 attenuates allergic airway inflammation and remodeling in asthmatic mice. Biomed Pharmacother. 2016;84:1820–1825.
   PubMed Web of Science ®Google Scholar
• Du P, Luo K, Li G, et al. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway. Bioengineered. 2021;12(1):5028–5044.
   PubMed Web of Science ®Google Scholar
• Yin D, Lu X. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells. Bioengineered. 2021;12(1):225–239.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhang X, Wang F, et al. [Construction of lentivirus plasmid pCDH-NLRX1 and stable expression of NLRX1 in A549 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36(2):152–156.
   PubMedGoogle Scholar
• Wu N, Zhang X, Bao Y, et al. Down-regulation of GAS5 ameliorates myocardial ischaemia/reperfusion injury via the miR-335/ROCK1/AKT/GSK-3β axis. J Cell Mol Med. 2019;23(12):8420–8431.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Vlachos IS, Karagkouni D, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44(D1):D231–8.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Z, Fan Z, et al. Involvement of non‑coding RNAs in the pathogenesis of myocardial ischemia/reperfusion injury (Review). Int J Mol Med. 2021;47(4):1.
   Web of Science ®Google Scholar
• Guan H, Shang G, Cui Y, et al. Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1. J Cell Physiol. 2019;234(6):8998–9007.
   PubMed Web of Science ®Google Scholar
• Shang G, Wang Y, Xu Y, et al. Long non-coding RNA TCONS_00041960 enhances osteogenesis and inhibits adipogenesis of rat bone marrow mesenchymal stem cell by targeting miR-204-5p and miR-125a-3p. J Cell Physiol. 2018;233(8):6041–6051.
   PubMed Web of Science ®Google Scholar
• Nilsson F, Storm P, Sozzi E, et al. Profiling of coding and noncoding genes in human dopamine neuron differentiation. Cells. 2021;10(1):137.
   PubMed Web of Science ®Google Scholar
• Yan S, Xu J, Liu B, et al. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway. Bioengineered. 2021;12(1):682–696.
   PubMed Web of Science ®Google Scholar
• Guan H, Mei Y, Mi Y, et al. Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells. Onco Targets Ther. 2018;11:4893–4899.
   PubMed Web of Science ®Google Scholar
• Sang Y, Tang J, Li S, et al. LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression. Sci Rep. 2016;6:22366.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen F, Zhan H, et al. lncRNA CASC9 sponges miR‑758‑3p to promote proliferation and EMT in bladder cancer by upregulating TGF‑β2. Oncol Rep. 2021;45(1):265–277.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Gao H. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p. Cancer Med. 2020;9(5):1830–1841.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Q, Quan Z. Long non-coding RNA CASC9 enhances breast cancer progression by promoting metastasis through the meditation of miR-215/TWIST2 signaling associated with TGF-β expression. Biochem Biophys Res Commun. 2019;515(4):644–650.
   PubMed Web of Science ®Google Scholar
• Gao W, Gao J, Chen L, et al. XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal. Bioengineered. 2019;10(1):261–270.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang Q, Lu H, et al. Suppression of lncRNA MALAT1 Reduces LPS- or IL-17A-induced inflammatory response in human middle ear epithelial cells via the NF-κB signaling pathway. Biomed Res Int. 2021;2021:8844119.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar